A New Breed of Clinical Study Is Emerging After FDA Allows Virtual Trials

Keerthi Vedantam

Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.

telehealth telemedicine generic
As the pandemic slowed and halted clinical trials to test new drugs, the need for a virtual solution became clear to clinical researchers. El Segundo-based Lightship hopes to keep clinical trials going with a virtual process that allows patients to participate from home.

The three-year-old company is one of many in Los Angeles, including MedVector and Science37, investing in a new model of clinical drug trials that seek to virtualize and speed up a yearslong, data-intensive process heavily regulated by the Food and Drug Administration. Those trials are key to help doctors understand the efficacy and side effects of drugs before dosing their patients.

The approach has proved attractive during a pandemic that has forced traditional drug trials to slow down as researchers scrambled to safely conduct trials without putting participants in danger of COVID-19.

SEC filings from Monday show the startup raised $40 million from 10 undisclosed investors. Neither Lightship nor its previous investors responded to requests for comment.

But the move comes as the Food and Drug Administration shifts its thinking on clinical trials. In November, the agency updated its standards to accommodate patients participating in clinical trials from home. It also acknowledged the process was largely unfair because it failed to include underrepresented patients.

In issuing the guidance, Commissioner Stephen M. Hahn acknowledged "clinical trials requiring frequent visits to specific sites may place an added burden on participants."

The clinical trial process often excludes underprivileged people who would otherwise be prime candidates for the drug. That's because it requires participants to drive to hospitals or research sites, sometimes during the work day.

Lightship, though tight-lipped about its products, says on its website it aims to construct flexible clinical trial solutions for companies that want to accommodate patients that can't drive to a nearby facility for regular testing.

That could help clinical trials solve their diversity problem that some researchers argue have plagued the industry.

Clinical trials depend on racial and financial diversity because a drug's efficacy isn't based solely on the chemical composition of the drug – it also requires an extensive understanding of different environmental factors, such as someone's quality of sleep, outside stressors and genetics. Those factors can influence a drug's performance and they are part of what the FDA considers when it creates a drug's safety profile for doctors and patients before releasing the drug onto the market.

"If you don't include a diverse population in your clinical trial and really study those differences or similarities, you might end up having a situation where the product is out in the market and it has a different safety and efficacy profile [than what was originally written]," said Dr. Eunjoo Pacifici, a professor at the USC School of Pharmacy.

Lightship previously raised $10 million in a debt financing round in April, and nearly $20 million in venture capital in 2020.

MedVector, another LA-based startup tackling the virtual clinical trial space, raised $630,000 in March for a product to help clinicians document a participant's vitals without requiring them to travel. Another, Science 37, raised $40 million in 2020 to construct flexible clinical trials.

Subscribe to our newsletter to catch every headline.


Genies Wants To Help Creators Build ‘Avatar Ecosystems’

Christian Hetrick

Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.

Genies Wants To Help Creators Build ‘Avatar Ecosystems’

When avatar startup Genies raised $150 million in April, the company released an unusual message to the public: “Farewell.”

The Marina del Rey-based unicorn, which makes cartoon-like avatars for celebrities and aims to “build an avatar for every single person on Earth,” didn’t go under. Rather, Genies announced it would stay quiet for a while to focus on building avatar-creation products.

Genies representatives told dot.LA that the firm is now seeking more creators to try its creation tools for 3D avatars, digital fashion items and virtual experiences. On Thursday, the startup launched a three-week program called DIY Collective, which will mentor and financially support up-and-coming creatives.

Read moreShow less

Here's What To Expect At LA Tech Week

Christian Hetrick

Christian Hetrick is dot.LA's Entertainment Tech Reporter. He was formerly a business reporter for the Philadelphia Inquirer and reported on New Jersey politics for the Observer and the Press of Atlantic City.

Here's What To Expect At LA Tech Week

LA Tech Week—a weeklong showcase of the region’s growing startup ecosystem—is coming this August.

The seven-day series of events, from Aug. 15 through Aug. 21, is a chance for the Los Angeles startup community to network, share insights and pitch themselves to investors. It comes a year after hundreds of people gathered for a similar event that allowed the L.A. tech community—often in the shadow of Silicon Valley—to flex its muscles.

From fireside chats with prominent founders to a panel on aerospace, here are some highlights from the roughly 30 events happening during LA Tech Week, including one hosted by dot.LA.

Read moreShow less

LA Tech ‘Moves’: HyperDraft Taps LegalZoom Exec

Decerry Donato

Decerry Donato is a reporter at dot.LA. Prior to that, she was an editorial fellow at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

LA Tech ‘Moves’: HyperDraft Taps LegalZoom Exec
Photo by James Opas | Modified by Joshua Letona

“Moves,” our roundup of job changes in L.A. tech, is presented by Interchange.LA, dot.LA's recruiting and career platform connecting Southern California's most exciting companies with top tech talent. Create a free Interchange.LA profile here—and if you're looking for ways to supercharge your recruiting efforts, find out more about Interchange.LA's white-glove recruiting service by emailing Sharmineh O’Farrill Lewis (sharmineh@dot.la). Please send job changes and personnel moves to moves@dot.la.

Read moreShow less